sexual dysfunction
Ridgefield, CT, November 16, 2009 - Data from pivotal Phase III clinical trials demonstrate that flibanserin 100mg increased the number of satisfying sexual events (SSE) and sexual desire (the co-primary endpoints) while decreasing the distress associated with Hypoactive Sexual Desire Disorder (HSDD).
November 11, 2009 (Oakland, Calif.) -- High levels of workplace exposure to Bisphenol-A may increase the risk of reduced sexual function in men, according to a Kaiser Permanente study appearing in
Pre- and post-menopausal women who self-rated themselves as being sexually satisfied had a higher overall psychological well-being score and scores for "positive well-being" and "vitality," compared with sexually dissatisfied women in a study of 295 women sexually active more than twice a month.
Bethesda, MD (Sept. 1, 2009) -- Sexual impairment is common among men with chronic hepatitis C undergoing antiviral therapy, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
New York, NY, June 18, 2009 -- Researchers have determined that individuals with mild to severe symptoms of lower urinary tract symptoms (LUTS) are more likely to suffer from metabolic syndrome (MetS), a collection of cardiovascular risk factors thought to be linked by insulin resistance).
Berkeley-- University of California, Berkeley, researchers have found what they think is a critical and, until now, missing piece of the puzzle about how stress causes sexual dysfunction and infertility.
A long-term study by researchers at UCLA's Jonsson Comprehensive Cancer Center found that the three most common treatments for localized prostate cancer had significant impacts on patients' quality of life, a finding that could help guide doctors and patients in making treatment decisions.
Prostate cancer patients who undergo therapy to decrease testosterone levels increase their risk of developing bone- and heart-related side effects compared to patients who do not take these medications, according to a new analysis.
LINTHICUM, MD, April 26, 2009-Two studies presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA) show that adult circumcision reduces the risk of contracting the human immunodeficiency virus (HIV) and the risk of coital injury!!--without reducing pleasure or causing sexual dysfunction.
More than 40 percent of women ages 18-59 experience sexual dysfunction, with lack of sexual interest -- hypoactive sexual desire disorder, or HSDD -- being the most commonly reported complaint, according to medical researchers.
Researchers have uncovered damage in a specific, primitive portion of the nervous systems of veterans suffering from Gulf War syndrome. Scientists report that damage to the parasympathetic nervous system may account for nearly half of the typical symptoms -- including gallbladder disease, unrefreshing sleep, depression, joint pain, chronic diarrhea and sexual dysfunction -- that afflict those with Gulf War syndrome. Their findings will be published in the October issue of the American Journal of Medicine and are currently available online.
A University of Alberta researcher has discovered a potential breakthrough for premature ejaculation--the most common sexual dysfunction in men--with a drug usually used to treat bi-polar or anxiety disorder. Dr. Pierre Chue, a psychiatry professor at the U of A, has found success in treating premature ejaculation (PE) with the use of gabapentin, better known by the brand name Neurontin. Chue writes about his findings in the September issue of the ''Canadian Journal of Psychiatry.'' ''This disorder affects almost 40 per cent of males--it is even more common than erectile dysfunction--yet it is not talked about much and there has been very little research on it,'' said Chue.
he largest study of UK Gulf war servicemen, published today in BMC Public Health confirms that forces deployed to the first Gulf War report more ill health than veterans who did not serve there. Rebecca Simmons, Noreen Maconochie and Pat Doyle from the London School of Hygiene and Tropical Medicine found that Gulf war veterans were more likely to report mood swings, memory loss/lack of concentration, night sweats, general fatigue and sexual dysfunction than armed forces personnel who had not served in the Gulf.
Drug companies are sponsoring creation of a new medical disorder known as female sexual dysfunction in order to build markets for drugs among women, despite controversy surrounding the medicalisation of sexual problems, finds an article in this week's British Medical Journal. Over the past six years, researchers with close ties to the pharmaceutical industry have been developing and defining the new disorder at company sponsored meetings, writes journalist Ray Moynihan.
